Individuals with T2DM manifest selective hepatic insulin resistance in which insulin fails to suppress gluconeogenesis but continues to activate lipogenesis, producing the deadly combination of hyperglycemia and hypertriglyceridemia. This evidence concerns the gene INS and Insulin resistance.